Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

NCT00113815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Seizure Disorder
Epilepsy
Seizures

Interventions

DRUG: topiramate
DRUG: topiramate
DRUG: topiramate
DRUG: placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.